Research Diagnosis Related Groups (DRG) level Readmission quality outcomes for Fox Chase Cancer Center located at 333 Cottman Ave, Philadelphia, PA, 19111 & includes data from NPIs 1730195017
*Readmission Rate is calculated from October 2016 to August 2019 and all other Quality Outcomes are calculated from October 2016 to September 2019.
Total Hospitalizations (Oct 2016 to Sep 2019) | Total Hospitalizations After Exclusion | Total Users | Readmission Rate(%) | Pennsylvania Total Hospitalizations (Oct 2016 to Sep 2019) | Pennsylvania Total Hospitalizations After Exclusion | Pennsylvania Total Users | Pennsylvania Readmission Rate(%) | National Total Hospitalizations ( Oct 2016 to Sep 2019) | National Total Hospitalizations After Exclusion | National Total Users | National Readmission Rate(%) | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
All Inpatient | 4,264 | 4,121 | ||||||||||
Surgical | 2,092 | 2,046 | ||||||||||
Non Surgical | 2,172 | 2,075 | ||||||||||
General Surgery | 940 | 911 | ||||||||||
Urology | 904 | 895 | ||||||||||
Oncology & Hematology | 640 | 603 | ||||||||||
General Medicine | 476 | 461 | ||||||||||
Gastroenterology & Endocrinology | 451 | 435 | ||||||||||
Pulmonology | 231 | 215 | ||||||||||
Colorectal | 199 | 196 | ||||||||||
Obstetrics & Gynecology | 164 | 161 | ||||||||||
Cardiovascular | 88 | 84 | ||||||||||
Orthopedics | 67 | 63 | ||||||||||
Obesity, Bariatric, Stomach & Duodenal | 63 | 60 | ||||||||||
Neurology | 31 | 29 |
Total Hospitalizations (Oct 2016 to Sep 2019) | Total Hospitalizations After Exclusion | Total Users | Readmission Rate(%) | Pennsylvania Total Hospitalizations (Oct 2016 to Sep 2019) | Pennsylvania Total Hospitalizations After Exclusion | Pennsylvania Total Users | Pennsylvania Readmission Rate(%) | National Total Hospitalizations ( Oct 2016 to Sep 2019) | National Total Hospitalizations After Exclusion | National Total Users | National Readmission Rate(%) | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Major Chest Procedures | ||||||||||||
DRG 164: MAJOR CHEST PROCEDURES WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
DRG 165: MAJOR CHEST PROCEDURES WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
DRG 163: MAJOR CHEST PROCEDURES WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
Other Respiratory System O.R. Procedures | ||||||||||||
DRG 167: OTHER RESPIRATORY SYSTEM O.R. PROCEDURES WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
DRG 166: OTHER RESPIRATORY SYSTEM O.R. PROCEDURES WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
Pancreas, Liver And Shunt Procedures | ||||||||||||
DRG 406: PANCREAS, LIVER AND SHUNT PROCEDURES WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
Other Digestive System O.R. Procedures | ||||||||||||
DRG 357: OTHER DIGESTIVE SYSTEM O.R. PROCEDURES WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
DRG 356: OTHER DIGESTIVE SYSTEM O.R. PROCEDURES WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
Myeloproliferative Disorders Or Poorly Differentiated Neoplasms With Major Procedure | ||||||||||||
DRG 827: MYELOPROLIFERATIVE DISORDERS OR POORLY DIFFERENTIATED NEOPLASMS WITH MAJOR O.R. PROCEDURE WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
Other Skin, Subcutaneous Tissue And Breast Procedures | ||||||||||||
DRG 580: OTHER SKIN, SUBCUTANEOUS TISSUE AND BREAST PROCEDURES WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
Extensive O.R. Procedure Unrelated To Principal Diagnosis | ||||||||||||
DRG 982: EXTENSIVE O.R. PROCEDURE UNRELATED TO PRINCIPAL DIAGNOSIS WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
DRG 981: EXTENSIVE O.R. PROCEDURE UNRELATED TO PRINCIPAL DIAGNOSIS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
Major Head And Neck Procedures | ||||||||||||
DRG 129: MAJOR HEAD AND NECK PROCEDURES WITH COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) OR MAJOR DEVICE | ||||||||||||
Peritoneal Adhesiolysis | ||||||||||||
DRG 336: PERITONEAL ADHESIOLYSIS WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
Tracheostomy For Face, Mouth And Neck Diagnoses Or Laryngectomy | ||||||||||||
DRG 012: TRACHEOSTOMY FOR FACE, MOUTH AND NECK DIAGNOSES WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
Skin Graft | ||||||||||||
DRG 577: SKIN GRAFT EXCEPT FOR SKIN ULCER OR CELLULITIS WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
Lymphoma And Leukemia With Major Procedure | ||||||||||||
DRG 821: LYMPHOMA AND LEUKEMIA WITH MAJOR O.R. PROCEDURE WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
Mastectomy For Malignancy | ||||||||||||
DRG 582: MASTECTOMY FOR MALIGNANCY WITH COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
Ecmo Or Tracheostomy With Mv >96 Hours Or Pdx Except Face, Mouth And Neck | ||||||||||||
DRG 003: ECMO OR TRACHEOSTOMY WITH MV >96 HOURS OR PDX EXCEPT FACE, MOUTH AND NECK WITH MAJOR O.R. PROCEDURE | ||||||||||||
Myeloproliferative Disorders Or Poorly Differentiated Neoplasms With Other Procedure | ||||||||||||
DRG 829: MYELOPROLIFERATIVE DISORDERS OR POORLY DIFFERENTIATED NEOPLASMS WITH OTHER O.R. PROCEDURE WITH COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
Adrenal And Pituitary Procedures | ||||||||||||
DRG 614: ADRENAL AND PITUITARY PROCEDURES WITH COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
Lymphoma And Non-Acute Leukemia With Other Procedure | ||||||||||||
Other Ear, Nose, Mouth And Throat O.R. Procedures | ||||||||||||
Major Procedures With Diagnosis Of Other Contact With Health Services | ||||||||||||
Other O.R. Procedures For Injuries | ||||||||||||
Non-Extensive Procedure Unrelated To Principal Diagnosis | ||||||||||||
Mouth Procedures | ||||||||||||
Hernia Procedures |
Total Hospitalizations (Oct 2016 to Sep 2019) | Total Hospitalizations After Exclusion | Total Users | Readmission Rate(%) | Pennsylvania Total Hospitalizations (Oct 2016 to Sep 2019) | Pennsylvania Total Hospitalizations After Exclusion | Pennsylvania Total Users | Pennsylvania Readmission Rate(%) | National Total Hospitalizations ( Oct 2016 to Sep 2019) | National Total Hospitalizations After Exclusion | National Total Users | National Readmission Rate(%) | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Kidney And Ureter Procedures | ||||||||||||
DRG 657: KIDNEY AND URETER PROCEDURES FOR NEOPLASM WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
DRG 658: KIDNEY AND URETER PROCEDURES FOR NEOPLASM WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
DRG 660: KIDNEY AND URETER PROCEDURES FOR NON-NEOPLASM WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
DRG 656: KIDNEY AND URETER PROCEDURES FOR NEOPLASM WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
Major Male Pelvic Procedures | ||||||||||||
DRG 708: MAJOR MALE PELVIC PROCEDURES WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
DRG 707: MAJOR MALE PELVIC PROCEDURES WITH COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
Major Bladder Procedures | ||||||||||||
DRG 654: MAJOR BLADDER PROCEDURES WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
DRG 653: MAJOR BLADDER PROCEDURES WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
Renal Failure | ||||||||||||
DRG 683: RENAL FAILURE WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
DRG 682: RENAL FAILURE WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
Transurethral Procedures | ||||||||||||
DRG 669: TRANSURETHRAL PROCEDURES WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
DRG 670: TRANSURETHRAL PROCEDURES WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
Kidney And Urinary Tract Infections | ||||||||||||
DRG 690: KIDNEY AND URINARY TRACT INFECTIONS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
DRG 689: KIDNEY AND URINARY TRACT INFECTIONS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
Other Kidney And Urinary Tract Diagnoses | ||||||||||||
DRG 699: OTHER KIDNEY AND URINARY TRACT DIAGNOSES WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
Urinary Stones | ||||||||||||
DRG 694: URINARY STONES WITHOUT ESW LITHOTRIPSY WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) |
Total Hospitalizations (Oct 2016 to Sep 2019) | Total Hospitalizations After Exclusion | Total Users | Readmission Rate(%) | Pennsylvania Total Hospitalizations (Oct 2016 to Sep 2019) | Pennsylvania Total Hospitalizations After Exclusion | Pennsylvania Total Users | Pennsylvania Readmission Rate(%) | National Total Hospitalizations ( Oct 2016 to Sep 2019) | National Total Hospitalizations After Exclusion | National Total Users | National Readmission Rate(%) | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Chemotherapy Without Acute Leukemia As Secondary Diagnosis | ||||||||||||
DRG 847: CHEMOTHERAPY WITHOUT ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
Digestive Malignancy | ||||||||||||
DRG 375: DIGESTIVE MALIGNANCY WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
DRG 374: DIGESTIVE MALIGNANCY WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
Respiratory Neoplasms | ||||||||||||
DRG 181: RESPIRATORY NEOPLASMS WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
DRG 180: RESPIRATORY NEOPLASMS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
Malignancy Of Hepatobiliary System Or Pancreas | ||||||||||||
DRG 435: MALIGNANCY OF HEPATOBILIARY SYSTEM OR PANCREAS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
DRG 436: MALIGNANCY OF HEPATOBILIARY SYSTEM OR PANCREAS WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
Major Hematological/Immunological Diagnoses Except Sickle Cell Crisis And Coagulation | ||||||||||||
DRG 809: MAJOR HEMATOLOGICAL AND IMMUNOLOGICAL DIAGNOSES EXCEPT SICKLE CELL CRISIS AND COAGULATION DISORDERS WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
DRG 808: MAJOR HEMATOLOGICAL AND IMMUNOLOGICAL DIAGNOSES EXCEPT SICKLE CELL CRISIS AND COAGULATION DISORDERS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
Nervous System Neoplasms | ||||||||||||
DRG 054: NERVOUS SYSTEM NEOPLASMS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
DRG 055: NERVOUS SYSTEM NEOPLASMS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
Lymphoma And Non-Acute Leukemia | ||||||||||||
DRG 841: LYMPHOMA AND NON-ACUTE LEUKEMIA WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
Other Myeloproliferative Disorders Or Poorly Differentiated Neoplasm Diagnoses | ||||||||||||
DRG 844: OTHER MYELOPROLIFERATIVE DISORDERS OR POORLY DIFFERENTIATED NEOPLASTIC DIAGNOSES WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
DRG 843: OTHER MYELOPROLIFERATIVE DISORDERS OR POORLY DIFFERENTIATED NEOPLASTIC DIAGNOSES WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
Kidney And Urinary Tract Neoplasms | ||||||||||||
DRG 687: KIDNEY AND URINARY TRACT NEOPLASMS WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
Red Blood Cell Disorders | ||||||||||||
DRG 812: RED BLOOD CELL DISORDERS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
Coagulation Disorders | ||||||||||||
DRG 813: COAGULATION DISORDERS |
Total Hospitalizations (Oct 2016 to Sep 2019) | Total Hospitalizations After Exclusion | Total Users | Readmission Rate(%) | Pennsylvania Total Hospitalizations (Oct 2016 to Sep 2019) | Pennsylvania Total Hospitalizations After Exclusion | Pennsylvania Total Users | Pennsylvania Readmission Rate(%) | National Total Hospitalizations ( Oct 2016 to Sep 2019) | National Total Hospitalizations After Exclusion | National Total Users | National Readmission Rate(%) | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Signs And Symptoms | ||||||||||||
DRG 948: SIGNS AND SYMPTOMS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
DRG 947: SIGNS AND SYMPTOMS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
Nutritional And Miscellaneous Metabolic Disorders | ||||||||||||
DRG 641: MISCELLANEOUS DISORDERS OF NUTRITION, METABOLISM , FLUIDS AND ELECTROLYTES WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
DRG 640: MISCELLANEOUS DISORDERS OF NUTRITION, METABOLISM , FLUIDS AND ELECTROLYTES WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
Septicemia Or Severe Sepsis | ||||||||||||
DRG 871: SEPTICEMIA OR SEVERE SEPSIS WITHOUT MV >96 HOURS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
DRG 872: SEPTICEMIA OR SEVERE SEPSIS WITHOUT MV >96 HOURS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
Postoperative And Post-Traumatic Infections | ||||||||||||
DRG 863: POSTOPERATIVE AND POST-TRAUMATIC INFECTIONS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
DRG 862: POSTOPERATIVE AND POST-TRAUMATIC INFECTIONS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
Complications Of Treatment | ||||||||||||
DRG 920: COMPLICATIONS OF TREATMENT WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
DRG 919: COMPLICATIONS OF TREATMENT WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
Cellulitis | ||||||||||||
DRG 603: CELLULITIS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
Disorders Of Liver Except Malignancy, Cirrhosis And Alcoholic Hepatitis | ||||||||||||
DRG 442: DISORDERS OF LIVER EXCEPT MALIGNANCY, CIRRHOSIS OR ALCOHOLIC HEPATITIS WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
Fever And Inflammatory Conditions | ||||||||||||
DRG 864: FEVER | ||||||||||||
Peptic Ulcer | ||||||||||||
Aftercare |
Total Hospitalizations (Oct 2016 to Sep 2019) | Total Hospitalizations After Exclusion | Total Users | Readmission Rate(%) | Pennsylvania Total Hospitalizations (Oct 2016 to Sep 2019) | Pennsylvania Total Hospitalizations After Exclusion | Pennsylvania Total Users | Pennsylvania Readmission Rate(%) | National Total Hospitalizations ( Oct 2016 to Sep 2019) | National Total Hospitalizations After Exclusion | National Total Users | National Readmission Rate(%) | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Other Digestive System Diagnoses | ||||||||||||
DRG 394: OTHER DIGESTIVE SYSTEM DIAGNOSES WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
DRG 393: OTHER DIGESTIVE SYSTEM DIAGNOSES WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
G.I. Obstruction | ||||||||||||
DRG 389: G.I. OBSTRUCTION WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
DRG 390: G.I. OBSTRUCTION WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
Esophagitis, Gastroenteritis And Miscellaneous Digestive Disorders | ||||||||||||
DRG 392: ESOPHAGITIS, GASTROENTERITIS AND MISCELLANEOUS DIGESTIVE DISORDERS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
DRG 391: ESOPHAGITIS, GASTROENTERITIS AND MISCELLANEOUS DIGESTIVE DISORDERS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
Disorders Of Biliary Tract | ||||||||||||
DRG 445: DISORDERS OF THE BILIARY TRACT WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
DRG 444: DISORDERS OF THE BILIARY TRACT WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
Major Gastrointestinal Disorders And Peritoneal Infections | ||||||||||||
DRG 372: MAJOR GASTROINTESTINAL DISORDERS AND PERITONEAL INFECTIONS WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
DRG 371: MAJOR GASTROINTESTINAL DISORDERS AND PERITONEAL INFECTIONS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
G.I.Hemorrhage | ||||||||||||
DRG 378: G.I. HEMORRHAGE WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
Endocrine Disorders | ||||||||||||
DRG 644: ENDOCRINE DISORDERS WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
Thyroid, Parathyroid And Thyroglossal Procedures | ||||||||||||
DRG 626: THYROID, PARATHYROID AND THYROGLOSSAL PROCEDURES WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
Disorders Of Pancreas Except Malignancy |
Total Hospitalizations (Oct 2016 to Sep 2019) | Total Hospitalizations After Exclusion | Total Users | Readmission Rate(%) | Pennsylvania Total Hospitalizations (Oct 2016 to Sep 2019) | Pennsylvania Total Hospitalizations After Exclusion | Pennsylvania Total Users | Pennsylvania Readmission Rate(%) | National Total Hospitalizations ( Oct 2016 to Sep 2019) | National Total Hospitalizations After Exclusion | National Total Users | National Readmission Rate(%) | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Simple Pneumonia And Pleurisy | ||||||||||||
DRG 194: SIMPLE PNEUMONIA AND PLEURISY WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
Respiratory Infections And Inflammations | ||||||||||||
DRG 178: RESPIRATORY INFECTIONS AND INFLAMMATIONS WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
Chronic Obstructive Pulmonary Disease | ||||||||||||
DRG 191: CHRONIC OBSTRUCTIVE PULMONARY DISEASE WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
Other Respiratory System Diagnoses | ||||||||||||
DRG 206: OTHER RESPIRATORY SYSTEM DIAGNOSES WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
Pulmonary Embolism | ||||||||||||
DRG 176: PULMONARY EMBOLISM WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
Pulmonary Edema And Respiratory Failure | ||||||||||||
DRG 189: PULMONARY EDEMA AND RESPIRATORY FAILURE | ||||||||||||
Pleural Effusion | ||||||||||||
DRG 187: PLEURAL EFFUSION WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
Pneumothorax | ||||||||||||
Respiratory System Diagnosis With Ventilator Support |
Total Hospitalizations (Oct 2016 to Sep 2019) | Total Hospitalizations After Exclusion | Total Users | Readmission Rate(%) | Pennsylvania Total Hospitalizations (Oct 2016 to Sep 2019) | Pennsylvania Total Hospitalizations After Exclusion | Pennsylvania Total Users | Pennsylvania Readmission Rate(%) | National Total Hospitalizations ( Oct 2016 to Sep 2019) | National Total Hospitalizations After Exclusion | National Total Users | National Readmission Rate(%) | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Major Small And Large Bowel Procedures | ||||||||||||
DRG 330: MAJOR SMALL AND LARGE BOWEL PROCEDURES WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
DRG 329: MAJOR SMALL AND LARGE BOWEL PROCEDURES WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
DRG 331: MAJOR SMALL AND LARGE BOWEL PROCEDURES WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) |
Total Hospitalizations (Oct 2016 to Sep 2019) | Total Hospitalizations After Exclusion | Total Users | Readmission Rate(%) | Pennsylvania Total Hospitalizations (Oct 2016 to Sep 2019) | Pennsylvania Total Hospitalizations After Exclusion | Pennsylvania Total Users | Pennsylvania Readmission Rate(%) | National Total Hospitalizations ( Oct 2016 to Sep 2019) | National Total Hospitalizations After Exclusion | National Total Users | National Readmission Rate(%) | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Uterine And Adnexal Procedures For Malignancy | ||||||||||||
DRG 740: UTERINE, ADNEXA PROCEDURES FOR NON-OVARIAN AND NON-ADNEXAL MALIGNANCY WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
DRG 737: UTERINE AND ADNEXA PROCEDURES FOR OVARIAN OR ADNEXAL MALIGNANCY WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
DRG 741: UTERINE, ADNEXA PROCEDURES FOR NON-OVARIAN AND NON-ADNEXAL MALIGNANCY WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
Uterine And Adnexal Procedures For Non-Malignancy | ||||||||||||
DRG 742: UTERINE AND ADNEXA PROCEDURES FOR NON-MALIGNANCY WITH COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
DRG 743: UTERINE AND ADNEXA PROCEDURES FOR NON-MALIGNANCY WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
Pelvic Evisceration, Radical Hysterectomy And Radical Vulvectomy | ||||||||||||
DRG 734: PELVIC EVISCERATION, RADICAL HYSTERECTOMY AND RADICAL VULVECTOMY WITH COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
Vagina, Cervix And Vulva Procedures |
Total Hospitalizations (Oct 2016 to Sep 2019) | Total Hospitalizations After Exclusion | Total Users | Readmission Rate(%) | Pennsylvania Total Hospitalizations (Oct 2016 to Sep 2019) | Pennsylvania Total Hospitalizations After Exclusion | Pennsylvania Total Users | Pennsylvania Readmission Rate(%) | National Total Hospitalizations ( Oct 2016 to Sep 2019) | National Total Hospitalizations After Exclusion | National Total Users | National Readmission Rate(%) | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Cardiac Arrhythmia And Conduction Disorders | ||||||||||||
DRG 309: CARDIAC ARRHYTHMIA AND CONDUCTION DISORDERS WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
Other Circulatory System Diagnoses | ||||||||||||
Peripheral Vascular Disorders |
Total Hospitalizations (Oct 2016 to Sep 2019) | Total Hospitalizations After Exclusion | Total Users | Readmission Rate(%) | Pennsylvania Total Hospitalizations (Oct 2016 to Sep 2019) | Pennsylvania Total Hospitalizations After Exclusion | Pennsylvania Total Users | Pennsylvania Readmission Rate(%) | National Total Hospitalizations ( Oct 2016 to Sep 2019) | National Total Hospitalizations After Exclusion | National Total Users | National Readmission Rate(%) | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Pathological Fractures And Musculoskeletal And Connective Tissue Malignancy | ||||||||||||
DRG 543: PATHOLOGICAL FRACTURES AND MUSCULOSKELETAL AND CONNECTIVE TISSUE MALIGNANCY WITH COMPLICATION OR COMORBIDITY (CC) |
Total Hospitalizations (Oct 2016 to Sep 2019) | Total Hospitalizations After Exclusion | Total Users | Readmission Rate(%) | Pennsylvania Total Hospitalizations (Oct 2016 to Sep 2019) | Pennsylvania Total Hospitalizations After Exclusion | Pennsylvania Total Users | Pennsylvania Readmission Rate(%) | National Total Hospitalizations ( Oct 2016 to Sep 2019) | National Total Hospitalizations After Exclusion | National Total Users | National Readmission Rate(%) | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Stomach, Esophageal And Duodenal Procedures | ||||||||||||
DRG 327: STOMACH, ESOPHAGEAL AND DUODENAL PROCEDURES WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
DRG 326: STOMACH, ESOPHAGEAL AND DUODENAL PROCEDURES WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
DRG 328: STOMACH, ESOPHAGEAL AND DUODENAL PROCEDURES WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) |